AbbVie Inc - Price To Sales Ratio

AbbVie Inc's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 6.33 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Price To Sales Ratio" stands at 6.33. This represents an increase of 18.48 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.96 percent compared to the value the year prior.
The 1 year change in percent is 7.96.
The 3 year change in percent is 53.80.

The Serie's long term average value is 4.95. It's latest available value, on 09/30/2025, is 27.80 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is +66.80%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.